Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Endocrinology
Diabetes Mellitus, Type 2
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Clinical Research for Type 2 Diabetes
Has your doctor told you your blood sugar level is not adequately controlled?
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you controlling your diabetes or is it controlling you?
From diagnosis to decision
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type 2 Diabetes Research Study (people not taking medications)
Type 2 Diabetes Research Study (people taking Actos® or Avandia®)
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
Do you have high blood sugars?
Type II Diabetes Research
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
High Blood Sugar Levels can affect Your Health.
Patients with type 2 diabetes needed for a clinical research trial.
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Is Diabetes a
Part of Your Life?
Type 2 Diabetes: Giving Medication a Try
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Type 2 Diabetes Study for patients on Actos (proglitazone) only.
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
Pediatric Type 2 Diabetes Study
Type II Diabetes / Renal Impairment Research Study
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A study to assess the effectiveness of PAP treatment on glycemic control (HbA1c) in patients with diabetes
A study to compare safety of an oral medication in Type 2 Diabetes patients
A study to evaluate the safety and efficacy of a medication at four dose levels in Diabetes Type 2 patients
Clinical Research Study for People with Type 2 Diabetes
Type 2 Diabetes Study that is evaluating the safety, efficacy and tolerability of the study drug, as an add-on treatment to Metformin (Glucophage), for the treatment of Type 2 Diabetes.
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Do you have Type 2 Diabetes?
Do you have Type II Diabetes?
Do you have Type II Diabetes?
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type II Diabetes Research
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Diabetes Type II
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you unable to Manage your Type 2 Diabetes with Diet and Exercise Alone?
Are you unable to manage your Type 2 Diabetes?
Study of an investigational medication for the treatment of type 2 diabetes
Hypertension and Type 2 Diabetes Outpatient Study
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Diabetes Type 2
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Diabetes Type 2
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you unable to Manage your Type 2 Diabetes with Diet and Exercise Alone?
Type 2 Diabetes Study
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
Do You Have Type 2 Diabetes?
Type II Diabetes Research
Type II Diabetes Research
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes Research
A study to evaluate the efficacy of the study medication MK-0941 as an add on therapy to patients on long acting basal insulin.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Can you tell me about the study drug?
Diabetes Shouldn’t Define You
Do you have type 2 diabetes?
Do you have Type 2 Diabetes? Consider Volunteering?
From diagnosis to decision. If you have type 2 diabetes there are a few things you should know
Have you been diagnosed with Type II Diabetes?
Raise your hand if you have type 2 diabetes
When your type 2 diabetes is out of control, finding harmony is essential
You may be eligible to join the EMERGE STUDY if you
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A study evaluating the effectiveness in treating Type 2 Diabetes with sitagliptin(Januvia) in combination with pioglitazone(Actos) in those who have inadequate glycemic control
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
DIABETES TYPE 2 RESEARCH STUDY
TYPE II DIABETES RESEARCH STUDY
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
TYPE 2 DIABETES Study -- The Power of Two
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination with Metformin in Subjects with Type 2 Diabetes.
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Type II Diabetes Research
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
16 Million People in the U.S. Have Type II Diabetes. Are You One of Them?
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Do you have type 2 diabetes?
Type II Diabetes Research
Type II Diabetes Research
Type II Diabetes Research
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Do you have Diabetes?
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and Class II Heart Failure.
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Type II Diabetes Research
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A 26 week randomized, multinational, open labelled, 2 armed, parallel group, treat-to-target once daily treatment trial with insulin detemir versus insulin glargine, both in combination with metformin in subjects with type 2 diabetes.
A multi-center, randomized double-blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as monotherapy in patients with type 2 diabetes.
A muti-center, randomized double blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as add-on therapy to metformin in patients with type 2 diabetes.
A muti-center, randomized double blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as add-on therapy to metformin in patients with type 2 diabetes.
A phase 2 randomized two-stage open-label multi-center 24-week to evaluate the efficacy safety and tolerability of itca650 in subjects with type 2 diabetes mellitus
A randomized double blind, placebo-controlled parallel-group multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of metformin in patients with type 2 diabetes not adequately controlled with metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Type II Diabetes Research
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Current treatment not controlling your Diabetes?
Need help controlling your Type II Diabetes?
Overweight with Type II Diabetes?
Type II Diabetes that is not controlled by medication
Uncontrolled Type II Diabetes`
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Harmony, a Global Type 2 Diabetes Program
The GetGOAL-P Study to evaluate the effectiveness of an investigational medication for people with type 2 diabetes.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
Have you been diagnosed with TYPE 2 DIABETES?
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Phase III Clinical Trial to Evaluate the Effectiveness of a DPP-IV Inhibitor as Adjuvant Therapy for Achieving Glycemic Control in Patients with Type II Diabetes
Type II Diabetes - Inhaled Insulin for the Control of Blood Sugar
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Diabetes Research Study
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
A study for newly diagnosed Type 2 diabetics or diabetics for whom diet and exercise are no longer enough
A study for people who have inadequately controlled Type 2 Diabetes
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Adult age 18-80 years with diabetes mellitus type 2 on metformin and pioglitazone.
Adults age 18-80 years with diabetes mellitus type 2 on metformin monotherapy or metformin in combination with a sulfonylurea.
Type II Diabetes Research
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
Type II Diabetes Research
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Do You Have Type II Diabetes?
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
An Adult Type 2 Diabetic Study
An Adult Type 2 Diabetic Study
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Diabetes: Do you have type 1 or type 2 diabetes? Or Do you have a relative with type 1 diabetes?
Diabetes: Have you recently been diagnosed with type 2 diabetes?
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Aleglitazar in Patients With Type 2 Diabetes
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type II Diabetes Research
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Do you have type 2 diabetes and are ready to stop struggling with your weight? Would you consider weight loss surgery OR be willing to participate in an intensive lifestyle program?
Seeking Volunteers ages 18-75 with Type 2 diabetes
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR MGH)
The Role of the Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Currently Looking for Patients for a Type 2 Diabetes Trial
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Research Study for Type II Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
Type II Diabetes Research
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A study evaluating an investigational medication for type II diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A study to evaluate the effectiveness of an investigational medication for people with type II diabetes.
A study to lower the risk of cardiovascular and renal health problem in type II diabetics.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type II Diabetes Research
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
Do you have Type II Diabetes and Chronic Kidney Disease?
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Do you take metformin for type 2 diabetes?
Type 2 Diabetes Research Study Diet Controlled
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A 16-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to compare the safety and efficacy of Starlix (nateglinide) vs. placebo in patients with type 2 diabetes who are inadequately controlled with basal insulin glargine in combination with metformin and/or thiazolidinedione (pioglitazone or rosiglitazone)
A Multi-center, Randomized, Open-label, Active Controlled, Parallel Arm Study to Compare the Efficacy of 12 Weeks of Treatment with Vildagliptin 100mg, qd to Thiazolidinedione (TZD) as Add-on Therapy in Patients with type 2 Diabetes Inadequately Controlled with Metformin Monotherapy in a Community-based Practice Setting
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Are you down in the dumps with your diabetes?
Pre-diabetes: Are you at risk?
The durability of twice daily insulin lispro low mixture compared to once daily insulin Glargine when added to existing oral therapy in patients with type 2 diabetes and inadequate glycemic control.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Are You a Type 2 Diabetic and Your Current Medications Are Just Not Enough?
Attention Type 2 Diabetics!
Do you have diabetes?
Do You Have Type 2 Diabetes? Are Diet and Exercise Not Working?
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
Diabetes Study CLCQ908A2203
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
ALTITUDE Diabetes Study CSPP100E2337
Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
DO YOU HAVE TYPE II DIABETES?
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Type II Diabetes Research
Type II Diabetes Research
Type 2 Diabetics
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
Targeting Inflammation using Salsalate for Type 2 Diabetes -TINSAL T2D
Type 2 Diabetes Mellitus - Adults
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Clinical trial to test how different doses of a study drug can help people with Type 2 Diabetes
Are You Diabetic? Do You Have High Blood Pressure?
DIABETES TYPE 2
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU]
A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU]
A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients with Type 2 Diabetes Treated with Once-Daily Insulin Glargine [H7U-MC-IDBA]
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Diabetes Study
Recently Diagnosed with Diabetes?
Suffering from Type II Diabetes?
The DURABLE Trial:
Assessing the DURAbility of Basal vs. Lispro Mix 25 Insulin Efficacy
The Durability of Twice-Daily Insulin Lispro Low Mixture
Compared to Once-Daily Insulin Glargine when
added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control [F3Z-US-IOOV]
Type II Diabetes Research
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Diabetes - Type2
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Do you have high blood sugar?
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
DIABETES Research Study
DIABETES: Is Diabetes a Part of Your Life?
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
DIABETES: Do you have Type 2 Diabetes?
DIABETES: Do you have Type 2 Diabetes?
DIABETES: Is metformin or metformin plus sulfonylurea the ONLY medication(s) you are taking for your diabetes?
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Are you a diabetic patient taking medicine to treat your high cholesterol?
Are you on insulin and suffer from Type 2 diabetes?
DIABETES: Is Diabetes a Part of Your Life?
Do you suffer from Type 2 diabetes?
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
DIABETES Research Study
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
DIABETES research volunteers needed
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
DIABETES (TYPE 2) Research Study
DIABETES Research Study
DIABETES Research Study
DIABETES: Are you taking Metformin for your Type 2 Diabetes?
DIABETES: Is metformin or metformin plus sulfonylurea the ONLY medication(s) you are taking for your diabetes?
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Type II Diabetes Research Study
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Volunteers Needed for a Clinical Research Trial of an Investigational Medication.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Are you a Type 2 Diabetic?
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
Type II Diabetes Research
Type II Diabetes Research
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type 2 Diabetes
Type 2 Diabetes
Type 2 Diabetes
Type 2 Diabetes
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Diabetes
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes - Diet Controlled
Type II Diabetes on Single or Multiple Medications
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes Research
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
Type II Diabetes Research
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
Have HIGH BLOOD PRESSURE and DIABETES TYPE II? We need your help in a study to evaluate the efficacy and safety of Aliskiren administered in combination with Valsartan versus Valsartan alone.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Overweight? Type 2 Diabetes?
Type 2 Diabetes Research Study
Type II Diabetes Research
Diabetes Study CLCQ908A2203
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Type II Diabetes Research
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
Are you overweight with type II diabetes?... You might qualify to participate in a new clinical study
Type II Diabetes Research
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
ALTITUDE Diabetes Study CSPP100E2337
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type II Diabetes Research
Recently diagnosed with Type 2 diabetes?
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin
Type II Diabetes Research
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
One Year Study for Type 2 Diabetes
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
Type II Diabetes Research
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
DIABETES Research Study
Type II Diabetes Research
Frustrated with type 2 diabetes?
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
Clinical trial to evaluate an investigational type 2 oral diabetes medication compared to a marketed diabetes medication.
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Is Type 2 Diabetes a Part of Your Life?
Type 2 Diabetes?
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of taspoglutide (RO5073031) compared to placebo in obese patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy
A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week main treatment period and an extension assessing the efficacy and safety of AVE0010 on top of pioglitazone in patients with type 2 diabetes not adequately controlled with pioglitazone.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Diabetes (Type 2) Research
Diabetes Research: Inhaled Insulin
Do you have uncontrolled type 2 diabetes and currently taking oral medications or using diet and exercise?
Do you or someone you know suffer from Diabetes Type II?
Type 2 Diabetes Research
Type II Diabetes Research
When your Type 2 Diabetes is out of control, finding harmony is essential
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Is Type 2 Diabetes a Part of Your Life?
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Type 2 Diabetes (ages 65+) - Houston, TX
Type II Diabetes Research
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Type II Diabetes Research
Type 2 Diabetes Research Study
Type 2 Diabetes Research Study
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Type II Diabetes Research
Type II Diabetes Research
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
A 4-Week, Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy of Saxagliptin in Combination With Metformin XR 1500 mg Versus Uptitrated Metformin XR to 2000 mg in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise and a Stable Dose of Metformin XR 1500 mg
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
A Study with RO5095932 in patients with type 2 diabetes on stable metformin therapy.
Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
Someday, instead of thinking and Diabetes medication every day of the week, it might only have to be one day.
To Your Good Health! Especially for You!
Type 2 Diabetes Research Study
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
Are you unable to manage your Type 2 Diabetes with diet and exercise alone?
You may be eligible to participate in a clinical research study.
If you have Type 2 Diabetes, and are between 18 and 80 years of age, and are currently treated with metformin, you may qualify to participate.
Raise your hand if you have Type 2 Diabetes!
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
Are you having a hard time controlling your Diabetes?
Diabetes Type 2: Could you have type 2 diabetes?
Diabetes Study CLCQ908A2203
Type II Diabetes- Patients currently taking Metformin
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.
Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Are you dealing with 'Sugar' (Diabetes)?
Volunteers 22-64 with DM2 needed for Kidney Study
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Diabetes Study CLCQ908A2203
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairmant
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
Are You Taking Insulin Shots or a Combination of Pills and Insulin Shots for Treatment of Type 2 Diabetes?
Diabetes: Inhaled Insulin Research
Diabetes: Are you taking ACTOS (pioglitazone) or AVANDIA (rosiglitazone) for Type 2 Diabetes?
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Research Study (#08186) Type 2 Diabetes
Research Study (#09060) Type 2 diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
Diabetes Study CLCQ908A2203
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
ALTITUDE Diabetes Study CSPP100E2337
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Aleglitazar in Patients With Type 2 Diabetes
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Drug-Drug Interaction Study of GK Activator (2) and Ethanol in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
A Study of Taspoglutide in Type 2 Diabetic Patients
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Study
